1. Home
  2. SHC vs AXSM Comparison

SHC vs AXSM Comparison

Compare SHC & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sotera Health Company

SHC

Sotera Health Company

HOLD

Current Price

$15.72

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$248.94

Market Cap

12.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHC
AXSM
Founded
2015
2012
Country
United States
United States
Employees
3000
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
12.0B
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
SHC
AXSM
Price
$15.72
$248.94
Analyst Decision
Buy
Strong Buy
Analyst Count
7
17
Target Price
$20.33
$211.12
AVG Volume (30 Days)
2.3M
594.1K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
68.75
38.56
EPS
0.09
N/A
Revenue
$1,163,617,000.00
N/A
Revenue This Year
$7.51
$57.24
Revenue Next Year
$6.00
$55.88
P/E Ratio
$175.28
N/A
Revenue Growth
5.74
N/A
52 Week Low
$10.94
$96.09
52 Week High
$19.85
$260.19

Technical Indicators

Market Signals
Indicator
SHC
AXSM
Relative Strength Index (RSI) 50.75 67.86
Support Level $15.00 $148.87
Resistance Level $16.47 N/A
Average True Range (ATR) 0.53 8.93
MACD -0.02 0.12
Stochastic Oscillator 50.61 77.49

Price Performance

Historical Comparison
SHC
AXSM

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: